Great Basin Scientific (GBSN) : During the past 4 weeks, traders have been relatively bearish on Great Basin Scientific (GBSN), hence the stock is down -70.84% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -40.79% relative to the S&P 500. The 4-week change in the price of the stock is -69.86% and the stock has fallen -40.83% in the past 1 week.
The stock has recorded a 20-day Moving Average of 58.86% and the 50-Day Moving Average is 70.68%. Great Basin Scientific, Inc. has dropped 84.25% during the last 3-month period . Year-to-Date the stock performance stands at -98.53%.
Great Basin Scientific (NASDAQ:GBSN): On Fridays trading session , Opening price of the stock was $0.54 with an intraday high of $0.54. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $0.47. However, the stock managed to close at $0.4852, a loss of 7.60% for the day. On the previous day, the stock had closed at $0.5251. The total traded volume of the day was 1,410,792 shares.
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease. The Company has a commercially available test, a diagnostic test for clostridium difficile (C. diff), which received clearance from the Food and Drug Administration (FDA). The Companys products under development also include a diagnostic test for Group B Strep., Staphylococcus Identification and Resistance Blood Infection Panel (Staph ID/R panel), STEC Test, Staph aureus (SA) Pre-Surgical Nasal Screen Test, Food Borne Pathogens Panel and Candida Blood Infection Panel. The Companys platform is an automated molecular diagnostic system, consisting of an analyzer and associated diagnostic tests.